INTRODUCTION
Over the past two and a half decades, MRI has become a critical tool for the diagnosis and management of human diseases, especially disorders of the central nervous system (CNS). The impact of MRI stems from the high-resolution images that are produced, which can be used to show the contrast between healthy and pathological tissue. In addition, gadolinium-based MRI contrast agents in routine clinical use are relatively well tolerated and are sensitive to specific pathologies, such as disruption of the blood-brain barrier caused by brain tumors 1 or multiple sclerosis, 2 as well as myocardial necrosis or fibrosis. 3 In the past 10 years, the range of applications for MRI has grown rapidly. This increase has been due largely to new functional MRI (fMRI) techniques developed in the late 1980s and early 1990s that have enabled the visualization of a wide range of physiological processes. Sensitizing MRI to water diffusion has enabled early viewing of tissue damage, providing important information for the diagnosis and treatment of stroke. 4,5 Development of techniques that take advantage of the anisotropic diffusion of water in white matter has led to rapidly increasing use of MRI to study white matter tracts in normal and diseased brain. 4, 6, 7 In addition, there have been attempts to use diffusion anisotropy to map fiber orientation in the heart. 8 Finally, the sensitivity of MRI to blood volume, 9 blood flow, 10 and, most importantly, blood oxygenation, 11 has led to detailed mapping of perfusion in the heart and has enabled the localization of brain activity during a wide range of cognitive tasks. 12, 13 Similarly, in the heart, quantitative perfusion techniques have begun to enable the characterization of myocardial blood flow, thereby providing an important index for assessing myocardial ischemia. 14 Thus, there has been a transformation from MRI applications aimed primarily at detecting anatomical markers of disease processes, toward MRI approaches that include A major goal of modern MRI research is to be able to image neural circuits in the central nervous system. Critical to this mission is the ability to describe a number of important parameters associated with neural circuits. These parameters include neural architecture, functional activation of neural circuits, anatomical and functional connectivity of neural circuits, and factors that might alter neural circuits, such as trafficking of immune cells and brain precursor cells in the brain. Remarkably, a variety of work in human and animal brains has demonstrated that all these features of neural circuits can be visualized with MRI. In this Article we provide a brief summary of the new directions in neural imaging research, which should prove useful in future analyses of normal and pathological human brains and in studies of animal models of neurological and psychiatric disorders. At present, few MRI data characterizing the neural circuits in the heart are available, but in this Article we discuss the applicable present developments and the prospects for the future.
the acquisition of functional information. Together with continued advances in magnetic resonance technologies and contrast agents, understanding of normal versus abnormal organ function has improved and has begun to have widespread clinical impact.
MRI techniques are continuing to develop at a fast pace. The anatomical and functional basis of neural circuits can be visualized at increasing resolutions with novel contrast agents sensitive to specific features of neural circuits. The majority of this work has been conducted with the CNS; however, it is anticipated that the lessons learned will have increasing applications in the peripheral nervous system. The goal of this Article is to emphasize the newer developments in MRI that are predicted to have a substantial impact on studies of normal and pathological brains in the next 5-10 years. Throughout the history of MRI of the brain, fruitful new directions have arisen from work in animal models, as well as in the human brain. We also discuss certain developments that are presently only applicable to animal models but that could be applicable to humans in the future, such as the development of novel contrast agents.
DIRECT VISUALIZATION OF FUNCTIONAL ARCHITECTURE IN THE BRAIN
In the CNS, MRI contrast has traditionally been used to distinguish gray matter, white matter, and cerebrospinal fluid, but application to detect structure within these tissues has been limited. In brain specimens, cytoarchitectural studies using a wide variety of histological stains have shown a remarkable degree of heterogeneity in white and gray matter structures. Indeed, histological stains have been used for decades to subdivide the brain into functional areas. [15] [16] [17] It would be a great step forward for defining neural circuits in vivo if MRI could directly visualize this functional heterogeneity. The ability to detect cortical myelin via MRI contrast was originally described by Clark and coworkers 18 as an approach to construct an in vivo cytoarchitectonic atlas of the brain. This idea has received renewed attention 19-21 but has not yet reached the point of widespread application. In animal brains, the detection of laminar structures with MRI has been limited to the olfactory bulb. 22 For detecting functional neuroanatomy, there has been much interest in using manganese chloride (MnCl 2 ) as an MRI contrast agent administered systemically to rodents. 23, 24 Typically, on the day following delivery, image features that define architectural boundaries are readily apparent. The laminar structures of the hippocampus, olfactory bulb, cerebellum, and cortex have been readily observed (Figure 1) . Use of laminar contrast to subdivide the brain into many functionally specific regions should be straightforward and has already been used to study the changes in brain architecture caused by disease in preclinical models of a wide range of neurological disorders. 25 MnCl 2 has also been used to image the heart, including the delineation of ischemic regions in pathologic hearts. 26 A drawback of the use of MnCl 2 is that it is a known neurotoxin; manganese (Mn 2+ ) is also an essential heavy metal. Hence, results from animal studies can be translated to humans only after careful consideration of safety.
Work with MRI at 7 T indicates that endogenous contrast may be used to characterize ncpcm_2007_189f1.eps a r t i c l e the details of functional neuroarchitecture. 27 The ability of MRI to study brain anatomy is primarily determined by resolution and contrast, both of which have improved dramatically due predominantly to the advent of high-field MRI and advances in detector technologies. 28, 29 At the laboratories of the NIH, increases in magnetic field strength to 7.0 T and the use of parallel detectors with up to 32 elements have increased sensitivity 10-fold to 25-fold (depending on the brain area) over that available with single-detector receivers at 1.5 T. This considerable improvement in sensitivity can be used to increase spatial resolution, and in human brains, pixel volumes of approximately 50 nl (equivalent to 350 μm isotropic voxels) have been acquired. 27,30 At these high magnetic fields, substantial contrast improvement can be achieved with so-called T2*-weighted or magnetic-susceptibility contrast. This type of MRI contrast is generated primarily by local variations in myelin, iron and deoxyhemoglobin concentrations and forms the basis for blood oxygen level-dependent fMRI. Susceptibility-weighted MRI contrast has been used previously to map the venous architecture in the brain. 31 With the high sensitivity and resolution afforded by 7.0 T, susceptibility contrast allows direct visualization of brain structures, such as specific major fiber bundles (Figure 2A ,B). This high-resolution identification of fiber bundles nicely complements the lower resolution information currently available with diffusion tensor MRI. 6 Potentially, in the future, individual fiber bundles will be followed to enable tractography between functional areas of the brain. In addition, susceptibility contrast variation across cortical layers is up to an order of magnitude higher than that described previously using T1-weighted MRI. 27 Thus, the individual layers in gray matter might be detected in the near future ( Figure 2C ). The robust detection of cortical heterogeneity should enable classification of functional brain regions in individuals. Furthermore, the high contrast and resolution available with susceptibility contrast during high field MRI make this technique promising for the study of diseases in which myelin, iron, or deoxyhemoglobin are locally altered, such as with multiple sclerosis 32 ( Figure 2D ), Alzheimer's disease, 33−35 brain tumors, 36 and stroke. 37 T 2 * contrast has been applied for studies of the heart as well as the brain. By adding exogenous T 2 * contrast agents, Vignaud et al. 38 have been able to map capillary orientation by looking at signal intensity as a function of orientation with respect to the magnetic field. T 2 * images of the rodent heart have shown exquisite anatomical features such as fiber orientation and the microvasculature. 39 Although there has not been widespread application to the heart as yet, the wide availability of high field MRI should increase the general usefulness of these approaches. 
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DETECTION OF CORRELATED NETWORK ACTIVITY WITH FUNCTIONAL MRI
Increasingly, MRI studies of the brain are aimed at the collection of functional information. The purpose of these studies is to develop a general understanding of normal brain function and to detect functional abnormalities associated with disease. These methods rely on contrast intrinsic to the physiological processes that underlie brain function-in particular, local increases in blood flow to regions of increased neuronal activity. This forms the basis of fMRI, which either directly, through perfusion fMRI, 10 or indirectly, through blood oxygen level-dependent fMRI, 11 allows detection of activity dependent blood-flow changes. The ability to noninvasively map brain activity has had a tremendous effect on the field of cognitive neuroscience. The localization of areas of the brain involved in complex cognitive tasks is now routine and has enabled the definition of the neuronal networks involved in a wide range of normal and abnormal behaviors. The temporal resolution of fMRI is presently too low to map the flow of information through neural circuits and most fMRI work relies on analyses of group data. Modeling and work that combines electroencephalography with fMRI, however, show great promise. 40, 41 These new developments in fMRI have important implications for understanding the cause and pathophysiology of diseases of the brain, and exciting new results facilitate understanding of brain plasticity following injury. The use of fMRI for biofeedback will expand the available clinical applications of this modality. Recently, the FDA has approved the use of fMRI for presurgical planning.
A few fMRI studies have been performed in order to investigate the input of CNS to the autonomic control of cardiovascular function. These studies have helped to define the role of the anterior cingulate cortex, the medial prefrontal cortex, and the insular cortex in regulating sympathetic outflow to the heart. 42 There is a growing body of evidence that links cortical dysfunction with dysfunction of autonomic control of the heart. 43 Future studies correlating fMRI with vagal nerve activity should improve the understanding of the role of the CNS in cardiovascular disease.
An interesting and promising new application of fMRI is the study of functional brain connectivity between activated brain regions. Studies have shown that spontaneous blood flow variations in the brain occur in distinct spatial patterns and that functionally related regions vary in a temporally correlated fashion. These so-called resting-state fluctuations, occurring in the absence of external stimuli, were first described in the motor cortex, and this work has shown that motor areas in different hemispheres covary in synchrony. 44 Increasingly, studies are attempting to separate the potential physiological and neuronal contributions to this phenomenon. Many groups have developed robust ways to remove potential MRI artifacts that can arise due to breathing or cardiac pulsations. 45 Importantly, a substantial metabolic cost has been attributed to resting-state fMRI fluctuations, strongly arguing for a neuronal contribution. 46 Whole-brain analyses of these resting-state correlations have shown that multiple independent spatial patterns exist, thereby potentially providing information about the brain's intrinsic communication and connectivity 47 (Figure 3) . Preliminary clinical studies have shown that these patterns are altered in various diseases, including Alzheimer's disease 48 and multiple sclerosis, 49 indicating that restingstate fMRI could be used diagnostically to assess dysfunctional connectivities. A drawback of fMRI studies is that they rely on vascular changes for contrast and are, therefore, dependent on proper neurovascular control. The biological basis of neurovascular control is clearly quite complex, 50 and MRI techniques that can more directly measure neuronal activity will be important for imaging neural circuits. One technique that has been developed is based on the use of Mn 2+ as a surrogate marker of calcium influx. It has been appreciated for many years that Mn 2+ can enter excitable cells via voltagegated calcium channels; thus influx and accumulation of Mn 2+ have been used to indicate active areas in rat brain. 51 This early work required breaking the blood-brain barrier to enable rapid access of Mn 2+ to the brain. Many groups working in a large range of animal models have used the activity dependence of Mn 2+ -enhanced MRI to map brain regions involved in a wide range of tasks. Work with the mouse auditory system 52 and rat hypothalmus 53 indicates that it might be possible to make activity maps without breaking the blood-brain barrier. Furthermore, Mn 2+ uptake into the heart is affected by cardiac workload, enabling MRI to estimate calcium influx into the heart. 54 Using fluorescent indicators of calcium as a model, preliminary endeavors to make MRI contrast agents that are capable of detecting rises in calcium associated with activity changes have been attempted. Agents that respond to changes in calcium by controlling the relaxivity of gadolinium chelates 55 or controlling the aggregation of iron oxide 56 have been proposed and are promising tools for measuring brain activity. Finally, there has been an interest in using MRI to directly detect the magnetic field produced by neuronal currents. 57 Although pilot studies have demonstrated the use of MRI to directly measure neuronal currents, the results remain controversial. Models that can predict the signal changes that may arise from neuronal currents will be critical to the development of this technology. 58 While still far from being well established, these innovative approaches to quantify neuronal activity offer promise for increasing the specificity of MRI for measuring brain and cardiac function.
EMERGING MRI APPROACHES FOR IMAGING NEURAL CIRCUITS In vivo neuronal tract tracing
While diffusion-tensor-based MRI tools have enabled detailed studies of white matter connectivity, 4 they have not as yet allowed the acquisition of the kind of detailed anatomical connectivity that classic neuronal tract tracers yield. A major drawback of classic tracers is that they all require histological procedures or optical imaging that is restricted to surface regions. The Mn 2+ ion has been discussed above because it enables anatomical MRI contrast and because it can accumulate in active regions. A third property of Mn 2+ is that it is transported in an anterograde direction in neurons and can cross synapses, making it possible to use Mn 2+ -enhanced MRI to ncpcm_2007_189f4.eps trace connections in the brain in a manner analogous to classic tract tracers. The first demonstration of the use of Mn 2+ -enhanced MRI for neuronal tract tracing was in the rodent olfactory and visual pathways. 59 Since then, the technique has been used in many species, such as nonhuman primates and song birds. 60 Mn 2+ -enhanced MRI has been used to visualize the regional connectivity in a wide variety of brain areas, attesting to the general applicability of this approach.
Preliminary experiments have indicated that the tracing properties of Mn 2+ will enable functional brain structures to be resolved. Connections from the thalamus to the cortex imaged with Mn 2+ allow visualization of the known preference for input into specific cortical layers. 61 Furthermore, individual glomeruli have been resolved with Mn 2+ as it migrates from the olfactory nerves into the glomerular layer of the olfactory bulb (Figure 4) . The tract tracing properties of Mn 2+ have enabled Mn 2+ -enhanced MRI to be applied to preclinical animal models of a range of diseases, such as Alzheimer's disease, 62 stroke, 63 and spinal cord injury. 64 There have been no reported attempts to use Mn 2+ to trace neural circuits in the heart; however, such studies should be possible.
Tracking cells important to brain function
Cell tracking is another area with the promise to have a considerable impact clinically judging by the results from the large number of preclinical MRI studies with animals. A number of groups have demonstrated that specific cells can be robustly labeled with a variety of MRI contrast agents; the trafficking of these cells can then be followed by MRI. 65 Both immune-cell infiltration into the brain 66 and stem cells injected into the brain can be followed. 67 Reports of the first human applications of this exciting new frontier have begun to appear. 67, 68 Using iron oxide contrast, it is possible to detect with MRI single cells both in vitro and in vivo. 69, 70 Furthermore, judicious injection of MRI contrast near the site of production of neural progenitors in the subventricular zone of rodents has enabled the imaging of the migration of these cells to the olfactory bulb. 71 Taken together, these results indicate that it will be possible to use MRI to understand the important emerging role of cell trafficking in remodeling neural circuits in both normal and diseased brains. The early results from studies using approved iron oxide contrast agents in humans indicate that this approach will have a large impact on the clinical uses of MRI.
CONCLUSIONS
The development of fMRI and diffusion tensorbased MRI tractography has led to an immense amount of research directed at imaging neural circuits of the human brain. There have been a large number of applications developed to permit these tools to study the normal brain and a wide range of diseases of the brain. The application of MRI to visualization of the anatomy and function of neural circuits in the heart is much more challenging. A number of interesting avenues are being explored, however, that have the potential to greatly expand the use of MRI for the imaging of neural circuits. With emerging higher resolutions, susceptibility weighted MRI of the human brain has demonstrated the potential to routinely measure the wide range of functional anatomy that exists in the brain. Similar results have been obtained from animal brains using contrast agents and, in particular, Mn 2+ -enhanced MRI. While much less work has been done with the heart, it is clear that these novel MRI approaches will enable better delineation of cardiac anatomy, especially fiber orientation and remodeling due to ischemia. fMRI is progressing from analyzing activation to looking at intrinsically correlated activity throughout the brain. All this work is limited by the complexities of using vascular responses to infer neural activity. A growing amount of work using fMRI techniques to study the role of the CNS in autonomic control is expected. Attempts to find MRI contrast associated directly with neuronal activity are receiving increasing attention. Finally, there has been a large drive to develop functional contrast or molecular contrast agents for imaging neural circuits. Mn 2+ -enhanced MRI to perform neural tract tracing and the rapidly growing application of MRI to visualize cell migration are two promising areas that have already been investigated in preclinical animal studies and are ripe for widespread application to the human brain. These new molecular imaging approaches are most actively being developed for studying cancer and the brain; however, extension to the heart should be possible. Taken together, we would argue that MRI is poised to continue to develop rapidly to enable increasingly sophisticated analyses of neural circuits in health and disease. a r t i c l e 
